Testosterone deficiency syndrome: Cellular and molecular mechanism of action

Current Aging Science

Volumn 6, Issue 1, 2013, Pages 115-124

  Carruthers, Malcolm ^a  

^a Centre for Men's Health   (United Kingdom)

Author keywords

Aging; Androgen; Androgen deficiency; Dhea; Diabetes; Erectile dysfunction; Insulin; Polyglutamine; Sex hormone binding globulin (shbg); Testes; Testis; Testosterone; Testosterone deficiency

Indexed keywords

ANDROGEN; ANDROGEN BINDING PROTEIN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANTIANDROGEN; GLYCINE; HEAT SHOCK PROTEIN; INSULIN; POLYGLUTAMINE;

AGING; ALCOHOL CONSUMPTION; ANDROGEN DEFICIENCY; ANDROGEN SYNTHESIS; ARTICLE; DIET; GENETIC POLYMORPHISM; HEREDITY; HUMAN; INCIDENCE; INFECTION; INJURY; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STRESS; TEMPERATURE; TESTOSTERONE SYNTHESIS; TISSUE REACTION;

ADULT; AGING; ALCOHOL DRINKING; ANIMALS; DIET, VEGETARIAN; HUMANS; INFECTION; MALE; MODELS, BIOLOGICAL; RECEPTORS, ANDROGEN; REFERENCE VALUES; STRESS, PHYSIOLOGICAL; SYNDROME; TESTICULAR DISEASES; TESTIS; TESTOSTERONE; TRANSCRIPTION FACTORS;

EID: 84882743669     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/18746098112059990008     Document Type: Article

References (61)

1. Himsworth HP. Mechanism of diabetes mellitus. Lancet 1939; 65: 118-71.
2. Werner AA. The male climacteric: report of two hundred and seventy- three cases. JAMA 1946; 132: 188-94.
3. Heller CG, Myers GB. The male climacteric: Its symptomatology, diagnosis and treatment. JAMA 1944; 126: 472-7.
4. Reiter T. Testosterone implantation: A clinical study of 240 implantations in ageing males. J Am Geriatr Soc 1963; 11: 540-50.
5. Carruthers M. ADAM: androgen deficiency in the adult male: causes, diagnosis and treatment. London and New York: Taylor & Francis; 2004.
6. Tremblay RR, Morales AJ. Canadian practice recommendations for screening, monitoring and treating men affected by andropause or partial androgen deficiency. Aging Male 1998; 1(3): 213-18.
7. Heinemann LAJ, Zimmermann T, Vermeulen A, Thiel C, Hummel W. A new 'aging males' symptoms' (AMS) rating scale. Aging Male 1999; 2(2): 105-14.
8. Kratzik C, Heinemann LA, Saad F, Thai DM, Rucklinger E. Composite screener for androgen deficiency related to the aging males' symptoms scale. Aging Male 2005; 8(3): 157-61.
9. T'Sjoen G, Feyen E, De Kuyper P, Comhaire F, Kaufman JM. Selfreferred patients in an aging male clinic: much more than androgen deficiency alone. Aging Male 2003; 6(3): 157-65.
10. Travison TG, Morley JE, Araujo AB, O'donnell AB, McKinlay JB. The relationship between libido and testosterone levels in aging men. J Clin Endocrinol Metab 2006; 91(7): 2509-13.
11. Kupelian V, Shabsigh R, Travison TG, Page ST, Araujo AB, McKinlay JB. Is there a relationship between sex hormones and erectile dysfunction? Results from the massachusetts Male Aging Study. J Urol 2006; 176(6): 2584-8.
12. Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006; 91(11): 4335-43.
13. Kelleher S, Conway AJ, Handelsman DJ. Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 2004; 89(8): 3813-17.
14. Collier CP, Morales A, Clark A, Lam M, Wynne-Edwards K, Black A. The significance of biological variation in the diagnosis of testosterone deficiency, and consideration of the relevance of total, free and bioavailable testosterone determinations. J Urol 2010; 183(6): 2294-9.
15. Carruthers M, Trinick TR, Wheeler MJ. Validity of androgen assays. Aging Male 2007; 10(2): 52-9.
16. Conway AJ, Handelsman DJ, Lording DW, Stuckey B, Zajac JD. Use, misuse and abuse of androgens. The Endocrine Society of Australia consensus guidelines for androgen prescribing. Med J Aust 2000; 172(5): 220-4.
17. Nieschlag E, Swerdloff R, Behre HM, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Aging Male 2005; 8(2): 56-8.
18. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006; 91(6): 1995-2010.
19. Vermeulen A. Declining androgens with age: an overview. In: Oddens B, Vermeulen A, eds. Androgens and the Aging Male. New York: The Parthenon Publishing Group; 1996, pp. 3-14.
20. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2002; 87(2): 589-98.
21. Mohr BA, Guay AT, O'donnell AB, McKinlay JB. Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Aging Study. Clin Endocrinol (Oxf) 2005; 62(1): 64-73.
22. Plymate SR, Tenover JS, Bremner WJ. Circadian variation in testosterone, sex hormone-binding globulin, and calculated non-sex hormone-binding globulin bound testosterone in healthy young and elderly men. J Androl 1989; 10(5): 366-71.
23. Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol (Oxf) 2003; 58(6): 710-17.
24. Neaves WB, Johnson L, Porter JC, Parker CR, Jr., Petty CS. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J Clin Endocrinol Metab 1984; 59(4): 756-63.
25. Suoranta H. Changes in small blood vessels of the adult human testes in relation to age: some pathological conditions. Virchows Archiv (Path Anat) 1971; 352: 765-81.
26. Holm M, Rajpert-De Meyts E, Andersson AM, Skakkebaek NE. Leydig cell micronodules are a common finding in testicular biopsies from men with impaired spermatogenesis and are associated with decreased testosterone/LH ratio. J Pathol 2003; 199(3): 378-86.
27. Clegg ED, Cook JC, Chapin RE, Foster PM, Daston GP. Leydig cell hyperplasia and adenoma formation: mechanisms and relevance to humans. Reprod Toxicol 1997; 11(1): 107-21.
28. Andersson AM, Jorgensen N, Frydelund-Larsen L, Rajpert-De Meyts E, Skakkebaek NE. Impaired Leydig cell function in infertile men: a study of 357 idiopathic infertile men and 318 proven fertile controls. J Clin Endocrinol Metab 2004; 89(7): 3161-67.
29. Meikle AW, Bishop DT, Stringham JD, West DW. Quantitating genetic and non genetic factors to determine plasma sex steroid variation in normal male twins. Metabolism 1987; 35: 1090-95.
30. Hogervorst E, Williams J, Budge M, Barnetson L, Combrinck M, Smith AD. Serum total testosterone is lower in men with Alzheimer's disease. Neuroendocrinol Lett 2001; 22(3): 163-8.
31. Elwan O, Abdallah M, Issa I, Taher Y, el Tamawy M. Hormonal changes in cerebral infarction in the young and elderly. J Neurol Sci 1990; 98(2-3): 235-43.
32. Okun MS, McDonald WM, DeLong MR. Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity. Arch Neurol 2002; 59(5): 807-11.
33. Dong Q, Hawker F, McWilliam D, Bangah M, Burger H, Handelsman DJ. Circulating immunoreactive inhibin and testosterone levels in men with critical illness. Clin Endocrinol 1992; 36(4): 399-404.
34. Sparrow D, Bosse R, Rowe JW. The influence of age, alcohol consumption, and body build on gonadal function in men. J Clin Endocrinol Metab 1980; 51(3): 508-12.
35. Badr FM, Bartke A, Dalterio S, Bulger W. Suppression of testosterone production by ethyl alcohol. Possible mode of action. Steroids 1977; 30(5): 647-55.
36. Rettori V, McCann SM. Role of nitric oxide and alcohol on gonadotropin release in vitro and in vivo. Ann NY Acad Sci 1998; 840: 185-93.
37. Wright J. Endocrine effects of alcohol. Clin Endocrinol Metab 1978; 7(2): 351-67.
38. Hamalainen EK, Adlercreutz H, Puska P, Pietinen P. Decrease of serum total and free testosterone during a low-fat high-fibre diet. J Steroid Biochem 1983; 18(3): 369-70.
39. Weinbauer GF, Gromoll J, Simoni M, Nieschlag E. Physiology of testicular function. In: Nieschlag E, Behre H, eds. Andrology: Male Reproductive Health and Dysfunction. Berlin: Springer; 1997, 25-57.
40. Shanbhag VP, Sodergard R. The temperature dependence of the binding of 5 alpha- dihydrotestosterone, testosterone and estradiol to the sex hormone globulin (SHBG) of human plasma. J Steroid Biochem 1986; 24(2): 549-55.
41. Bujan L, Daudin M, Charlet JP, Thonneau P, Mieusset R. Increase in scrotal temperature in car drivers. Hum Reprod 2000; 15(6): 1355-7.
42. Carruthers M. Male Menopause: Restoring Vitality and Virility. London: Harper Collins, 1996.
43. Pardridge WM. Transport of protein-bound hormones into tissues in vivo. Endocr Rev 1981; 2(1): 103-23.
44. Longcope C, Feldman HA, McKinlay JB, Araujo AB. Diet and sex hormone-binding globulin. J Clin Endocrinol Metab 2000; 85(1): 293-6.
45. Anderson DC. Sex-hormone-binding globulin. Clin Endocrinol 1974; 3: 69-96.
46. Traish AM, Kim N. Weapons of penile smooth muscle destruction: Androgen deficiency promotes accumulation of adipocytes in the corpus cavernosum. Aging Male 2005; 8(3): 141-6.
47. Traish AM, Guay AT. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med 2006; 3(3): 382-404.
48. Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2006; 154(6):899-906.
49. Foresta C, Caretta N, Lana A, De Toni L, Biagioli A, Ferlin A et al. Reduced number of circulating endothelial progenitor cells in hypogonadal men. J Clin Endocrinol Metab 2006; 91(11):4599-602.
50. Lewis RW, Mills TM. Effect of androgens on penile tissue. Endocrine 2004; 23(2-3):101-5.
51. Traish AM, Goldstein I, Kim NN. Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol. 2007; 52(1): 54-70.
52. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89(6):2548-56.
53. Kapoor D, Malkin CJ, Channer KS, Jones TH. Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf) 2005; 63(3): 239-50.
54. Pitteloud N, Mootha VK, Dwyer AA, et al. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 2005; 28(7):1636-42.
55. Skakkebaek NE, Jorgensen N. Testicular dysgenesis and fertility. Andrologia 2005; 37(6): 217-8.
56. Zitzmann M, Nieschlag E. The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl 2003; 26(2): 76-83.
57. Cardozo CP, Michaud C, Ost MC, et al. C-terminal Hsp-interacting protein slows androgen receptor synthesis and reduces its rate of degradation. Arch Biochem Biophys 2003; 410(1):134-40.
58. Fu M, Rao M, Wang C, et al. Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol Cell Biol 2003; 23(23):8563-75.
59. Lazarou S, Reyes-Vallejo L, Morgentaler A. Wide variability in laboratory reference values for serum testosterone. J Sex Med 2006; 3(6):1085-9.
60. Black AM, Day AG, Morales A. The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: can a case be made for a 3-month therapeutic trial? BJU Int 2004; 94(7): 1066-70.
61. Carruthers M. The paradox dividing testosterone deficiency symptoms and androgen assays: a closer look at the cellular and molecular mechanisms of androgen action. J Sex Med 2008; 5(4): 998-1012.